These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25632648)

  • 1. Omalizumab (Xolair) for the treatment of chronic idiopathic urticarial.
    Scheinfeld N
    Skinmed; 2014; 12(5):294-7. PubMed ID: 25632648
    [No Abstract]   [Full Text] [Related]  

  • 2. Omalizumab in chronic urticaria.
    Metz M; Maurer M
    Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):406-11. PubMed ID: 22766620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential role of omalizumab in the treatment of chronic urticaria.
    Stitt JM; Dreskin SC
    Immunotherapy; 2014; 6(6):691-7. PubMed ID: 25186602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in quality of life impairment followed by relapse with 6-monthly periodic administration of omalizumab for severe treatment-refractory chronic urticaria and urticarial vasculitis.
    Kai AC; Flohr C; Grattan CE
    Clin Exp Dermatol; 2014 Jul; 39(5):651-2. PubMed ID: 24758481
    [No Abstract]   [Full Text] [Related]  

  • 5. Omalizumab (Xolair) for chronic urticaria.
    Med Lett Drugs Ther; 2013 May; 55(1417):43-4. PubMed ID: 23715129
    [No Abstract]   [Full Text] [Related]  

  • 6. Omalizumab in the treatment of chronic urticaria.
    Francés L; Leiva-Salinas M; Silvestre JF
    Actas Dermosifiliogr; 2014; 105(1):45-52. PubMed ID: 23938072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omalizumab for chronic urticaria.
    Casale TB
    J Allergy Clin Immunol Pract; 2014; 2(1):118-9. PubMed ID: 24565785
    [No Abstract]   [Full Text] [Related]  

  • 8. Extraordinary response to omalizumab in a child with severe chronic urticaria.
    Asero R; Casalone R; Iemoli E
    Eur Ann Allergy Clin Immunol; 2014 Jan; 46(1):41-2. PubMed ID: 24702874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic urticaria: omalizumab and review of therapeutic options.
    Bergstrom KG
    J Drugs Dermatol; 2013 Jun; 12(6):715-6. PubMed ID: 23839196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of omalizumab in a patient with three types of chronic urticaria.
    Vieira Dos Santos R; Locks Bidese B; Rabello de Souza J; Maurer M
    Br J Dermatol; 2014 Feb; 170(2):469-71. PubMed ID: 24102388
    [No Abstract]   [Full Text] [Related]  

  • 11. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.
    Metz M; Ohanyan T; Church MK; Maurer M
    J Dermatol Sci; 2014 Jan; 73(1):57-62. PubMed ID: 24060603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.
    Kaplan A; Ledford D; Ashby M; Canvin J; Zazzali JL; Conner E; Veith J; Kamath N; Staubach P; Jakob T; Stirling RG; Kuna P; Berger W; Maurer M; Rosén K
    J Allergy Clin Immunol; 2013 Jul; 132(1):101-9. PubMed ID: 23810097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.
    Maurer M; Rosén K; Hsieh HJ; Saini S; Grattan C; Gimenéz-Arnau A; Agarwal S; Doyle R; Canvin J; Kaplan A; Casale T
    N Engl J Med; 2013 Mar; 368(10):924-35. PubMed ID: 23432142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedema.
    Lang DM
    Ann Allergy Asthma Immunol; 2014 Apr; 112(4):276-9. PubMed ID: 24589165
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.
    Sabroe RA
    Br J Dermatol; 2014 Jul; 171(1):13-5. PubMed ID: 25066289
    [No Abstract]   [Full Text] [Related]  

  • 16. Omalizumab in chronic urticaria: a retrospective series of 15 cases.
    Armengot-Carbo M; Velasco-Pastor M; Rodrigo-Nicolas B; Pont-Sanjuan V; Quecedo-Estebanez E; Gimeno-Carpio E
    Dermatol Ther; 2013; 26(3):257-9. PubMed ID: 23742285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal.
    Durack A; Matin RN
    Br J Dermatol; 2014 Jul; 171(1):10-3. PubMed ID: 25066288
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapy of chronic urticaria: a simple, modern approach.
    Kaplan AP
    Ann Allergy Asthma Immunol; 2014 May; 112(5):419-25. PubMed ID: 24656924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria.
    Song CH; Stern S; Giruparajah M; Berlin N; Sussman GL
    Ann Allergy Asthma Immunol; 2013 Feb; 110(2):113-7. PubMed ID: 23352531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria.
    Chang TW; Chen C; Lin CJ; Metz M; Church MK; Maurer M
    J Allergy Clin Immunol; 2015 Feb; 135(2):337-42. PubMed ID: 24948369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.